Clinical Trial Update: Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating primaquine's gametocytocidal efficacy in asymptomatic malaria carriers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 3 | Status: COMPLETED